At Saince, we build the technological foundation that empowers providers to focus entirely on their patients. By seamlessly integrating artificial intelligence, cloud-native infrastructure, and deep system interoperability, we are eliminating inefficiencies and bringing clinical information, radiology, and hospital management into the modern era. We are not just a service provider—we are a high-tech innovation engine for the healthcare industry.

USA: 5490 McGinnis Village Place, Suite 116, Alpharetta, GA 30005.
+1 888 472 4623 | sales@saince.com
INDIA: Corporate Address: #6-3-1090, Ground Floor, Block B, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad, Telangana 500082.
Registered Address: #202, Shatabdi Residency, Ramnagargundu, Hyderabad, Telangana 500044.
+91 40 6728 5555 | sales@saince.in
Contact Us
Address 5490 McGinnis Village Place, Suite 116, Alpharetta, GA 30005.
Follow Us

Clinical documentation, imaging and intelligence solutions.

Blog Details

Blogs
Novel Nuclear Imaging Probe Rapidly Assesses Treatment Response in Gastric Cancer January 23, 2022

Novel Nuclear Imaging Probe Rapidly Assesses Treatment Response in Gastric Cancer

A novel nuclear imaging probe can measure a gastric cancer patient’s response to treatment within days, marking a potential breakthrough that could enable patients who aren’t responding to treatment to get moved quickly to potentially more effective therapies

Current imaging modalities show tumor size, but it may take weeks before any perceptible change is demonstrated that can indicate whether the treatment is working. There is a need for new imaging approaches so that patients can be scanned within a few days after receiving treatment to see if it’s working or not.

Read more: https://www.hospimedica.com/critical-care/articles/294791225/novel-nuclear-imaging-probe-rapidly-assesses-treatment-response-in-gastric-cancer.html